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INTRODUCTION 
In the coming years we will need more 
biological control ratherthan less. The 
threat of alien invasive pests is acceler-
ating in many régions due to increased 
international travel and trade. For ex-
ample, just since 1992 three foreign 
insect pests (citrus leafminer, Phylloc-
nistis citrella; citrus psylla, Diaphorina 
citri; and brown citrus aphid, Toxoptera 
citricida) hâve invaded Florida's citrus 
groves. Because the integrated pest 
management (IPM) program for citrus 
in Florida is based on biological con-
trol, thèse newiy-introduced pests must 
be managed in a manner that does not 
disrupt the effective natural enemies 
that suppress mites, whiteflies, mealy-
bugs, scales, leafminers, and other ar-
thropods. We are on a "biological 
control treadmill" in Florida citrus be-
cause the introduction of a single new 
pest that cannot be controlled in a 
manner compatible with a biological-
control based IPM program threatens 
to disrupt the entire System. 
In the USA, Président Clinton set a 
goal of having the majority of US 
agriculture under IPM by the year 
2000. If new pests are controlled by 
nontoxic methods (including mating 
disruption, stérile insect releases), for-
merly suppressed pests may become 
apparent. A number of thèse so-called 
"secondary pests" may become targets 
of augmentative or conservation bio-
logical control programs. The increased 
importance of biological control will 
probably be international in scope as 
consumers become more concerned 
about the potential health risks associ-
ated with pesticide residues in food and 
water. 
With the introduction of new and 
stricter législation (such as the Food 
Quality Protection Act in the USA) re-
garding pesticide residues on foods, 
biological control will become more 
importantthan it is today in cotton, corn, 
wheat, rice, and other row crops. Some 
pests may be brought under control by 
the deployment of transgenic crops and 
this coula" provide new opportunities 
for biological control if the transgenic 




Despite the promise that biological 
control can reduce pesticide use and 
their detrimental effects on the envi-
ronment and human health, classical 
biological control currently is under 
attack around the world because of 
concerns about potential risks to the 
environment, especially to nontarget 
insects and plants. This has raised is-
sues that are both useful and disruptive 
to the use of classical and augmenta-
tive biological control. The increased 
focus on importing host-specific natu-
ral enemies is appropriate and should 
resuit in improved efficacy as well as 
fewer effects on nontarget species. Yet, 
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as a classical biological control practi-
tioner, I find that thèse concerns hâve 
created problems that can delay pro-
grams and make them more expensive. 
There is concern that the production of 
transgenic natural enemies will intensi-
fy the scrutiny of biological control by 




Ourabilityto develop transgenic insects 
and mites is improving rapidly (Ash-
burner et al. 1998) and offers the pos-
sibilité that genetically-improved natu-
ral enemies could be developed. 
However, there are several important 
research and policy issues to be re-
solved before such modified natural 
enemies can be deployed in practical 
pest management programs (Hoy 
1992a,b, 1995). 
The development of transgenic ar-
thropods on a routine basis is still very 
much a developing field (Hoy 1993, 
Ashburner et al. 1998). Transformation 
methods are still being improved; rela-
tively few marker gènes are available 
that allow unequivocal identification of 
transformed insects; few promoters and 
other regulatory séquences are avail-
able to allow transgenes to be tran-
scribed in the appropriate amounts in 
the appropriate tissues at the appropri-
ate time. Few gènes hâve been cloned 
that could be used to improve the effi-
cacy of arthropod natural enemies. It 
could be some years before transgenic 
natural enemies with useful (not just 
marker) gènes are produced for practi-
cal pest management programs. 
1) Will funds become available for de-
veloping transgenic arthropod natu-
ral enemies? Most classical biolog-
ical control programs are carried out 
by public sector agencies, which of-
ten lack sufficient funds to develop 
transgenic natural enemies. I know 
of no commercial entity interested in 
developing transgenic arthropod nat-
ural enemies because the time re-
quired to deploy the agent in the field 
is perceived to be too long, the pay-
offs uncertain, and the regulatory and 
risk assessment issues remain unre-
solved. Most companies involved in 
mass production of natural enemies 
for augmentative releases (and one 
can expect transgenic natural ene-
mies would be particularly useful in 
augmentative biological control) are 
small and hâve very limited research 
budgets that would preclude them 
from investing in such long term 
research. 
2) Are transgenic natural enemies in-
herently more risky than non-modi-
fied natural enemies? It is not a new 
question: the debate about risk in 
transgenic crop plants serves as a 
model with two divergent opinions 
based on differing assumptions: one 
group considers that transgenic tech-
nology is new and unique and that 
transgenic organisms need to be 
considered very carefully no matter 
the genetic change (transgenic organ-
isms are inherently risky). The other 
group would argue that transgenic 
technology is not significantly différ-
ent from conventional genetic ma-
nipulation. This group argues that 
régulations and évaluation should 
focus on spécifie traits that may be 
related to risk ratherthan on the spé-
cifie genetic manipulation method. 
3)What kind of risk assessment and 
régulation should be imposed on 
transgenic arthropod natural ene-
mies? 
At présent, in the USA, short term 
releases of transgenic arthropods are 
regulated by the USDA-APHIS, as de-
scribed in détail atthe following web-
site: (http://www.aph is.usda.gov:80/ 
bbep/bp/arthropod/#tgenadoc). As-
sessments are based on the princi-
pes outlined in Table 1. The appli-
cant to the USDA-APHIS is expected 
to demonstrate how the transgenic 
arthropod will be contained in the 
release plot and retrieved (or mitigat-
ed should it escape). The only trans-
genic arthropod released to date is a 
natural enemy, a predatory phytosei-
id with a low rate of dispersai (Hoy et 
al. 1997, McDermott and Hoy 1997). 
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Table 1. Some issues to résolve relating to risks of releasing transgenicarthropods into 
expérimental field plots 
A. Attributes of the Un modified Organism 
• What is the origin of the transgenic organism (indigenous or nonindigenous) in the 
accessible environment? 
• What is the arthropod's trophic level and host range? 
• What other ecological relationships does it hâve? 
• How easy is it to monitor and control? 
• How does it survive during periods of environmental stress? 
• What is the potential for gène exchange with other populations? 
• Is the arthropod involved in basic ecosystem processes? 
B. Attributes of the Genetic Altération 
• What is the intent of the genetic altération? 
• What is the nature and function of the genetic altération? 
• How well characterized is the genetic modification? 
• How stable is the genetic altération? 
C. Phenotype of Modified Organism Compared to Unmodified Organism 
• What is the host/prey range? 
• How fit and effective is the transgenic strain? 
• What is the expression level of the trait? 
• Has the altération changed the organism's susceptibility to control by natural or artificial 
means? 
• What are the environmental limits to growth or reproduction (habitat, microhabitat)? 
• How similar is the transgenic strain being tested to phenotypes 
• previously evaluated in field tests? 
D. Attributes of the Accessible Environment 
• Describe the accessible environment, whether there are alternate hosts or prey, wild 
relatives within dispersai capability of the organisms, and the relationship of the site 
to the potential géographie range of the transgenic arthropod strain. 
• Are there endangered/threatened species présent that could be affected? 
• Are there vectors or agents of indirect dissémination présent in theenvironment? 
• Do the test conditions provide a realistic simulation to nature? 
• How effective are the monitoring and mitigation plans? 
Modified from a discussion held at a conférence on "Risks of Releasing Transgenic Arthropod Natural 
Enemies", held November 13-16, 1993 in Gainesville, Florida (Hoy 1995). 
However, appl icat ion may soon be 
made to release the f i rst pest insect 
in the USA, a stéri le t ransgenic pink 
bo l lworms conta in ing a marker gène 
(green f luorescent protein) as part of 
a stéri le insect release program. No 
transgenic ar thropod has been re-
leased permanent ly into the env i ron-
ment and there are no guidel ines as 
to wha t data or assessments w o u l d 
be required to a l low such releases. 
Extensive efforts are being made to 
develop transgenic insects (or their 
symbionts) that are vectors of hu-
man or animal diseases. For exam-
ple, many laborator ies are at tempt-
ing to develop mosqui toes unable to 
vector malaria. Transformat ion of gut 
symbionts of Chagas' disease vec-
tors has been achieved and f ie ld t r i -
als may be conducted in Guatemala 
to détermine if t ransmiss ion of the 
pathogen can be reduced. Risk as-
sessments w i l l hâve to involve both 
ecological risks and human health and 
ethical issues. 
A crucial quest ion is: How can trans-
genic ar thropod natural enemies be 
evaluated for risk in short te rm re-
leases in a realistic manner when they 
hâve a higher dispersai abi l i ty than 
do transgenic plants and microorgan-
isms? How can thèse natural ene-
mies be contained effectively in the 
release site, yet be evaluated in an 
appropr iate manner? 
Because augmentat ive releases can 
be commercialized, thèse natural en-
emies could be genetically modified 
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using recombinant DNA methods and 
the costs recovered from consumers. 
What régulations and risk issues 
should govern private sector organi-
zations and who should enforce 
them? 
4) The issue of what level of risk is 
acceptable in biological control has 
to be resolved (Samways 1997). How 
do we measure costs, benefits, and 
risk? What assumptions are made? 
I don't think that scientists alone can 
(or should) make thèse décisions. 
RESEARCH NEEDS 
DTransformat ion methods, useful 
gènes, and appropriate promoters 
must be developed for arthropod 
natural enemies. Molecular methods 
used to insert transgenes into the 
chromosome of an insect may not be 
universally suitable for transforming 
diverse species; spécifie methods may 
hâve to be developed for each group. 
Millions of (US) dollars hâve been 
spent to identify useful gènes for 
transforming mosquitoes or other 
vectors of human disease, but almost 
nothing has been invested to identify 
gènes to improve the effectiveness 
of arthropod natural enemies. The 
gènes that being identifed in the 
Drosophila Génome Project may pro-
vide an entre to useful gènes in the 
génomes of arthropod natural ene-
mies, but almost no effort is being 
devoted to this. 
2) Horizontal gène transfer of inserted 
transgenes is a potential risk for any 
transgenic organism. We know that 
horizontal gène transfer is a natural 
evolutionary force and that it is rare, 
occurring on an "evolutionary time 
scale". What level of risk can we 
tolerate? What mechanisms allow 
horizontal gène transfer? Much re-
search needs to be conducted on the 
risks of horizontal gène transfer, but 
such research is very difficult and ex-
pensive. Some even argue that we 
cannot study horizontal gène trans-
fer in laboratory experiments because 
it is so rare. This research should, 
however, be a high priority. 
3) Releases of transgenic arthropod 
natural enemies will be made with 
the assumption that they will retain 
their expected host or prey préfér-
ences and climatic tolérances. Each 
transgenic population will hâve to be 
evaluated under laboratory condi-
tions to confirm that it remains host/ 
prey spécifie and that we can predict 
its géographie range after its release. 
What laboratory tests and models are 
sufficient to predict this? 
4) Is it possible to develop "crippled" 
transgenic arthropod natural enemies 
that are unable to permanently es-
tablish in the environment (perhaps 
because they lack the ability to dia-
pause or otherwise cannot tolerate 
climatic conditions throughout the 
year)? Such organisms may be use-
ful for augmentative biological con-
trol and would hâve the added ad-
vantage that the commercial entity 
could sell the new strain each grow-
ing season. The ability to produce 
effective natural enemies that are un-
able to multiply or persist in the en-
vironment will require research to 
identify or clone suitable gènes. 
5) The mass production and deployment 
of transgenic natural enemies will 
create problems already encountered 
in the mass rearing of nonmodified 
natural enemies-loss of genetic vari-
ability through inbreeding and genetic 
bottlenecks, inadvertent sélection for 
laboratory adaptation, and the fail-
ure of artificial rearing conditions to 
allow healthy and fit individuals to 
develop. Research aimed at improv-
ing rearing methods for natural ene-
mies will provide benefits broadly to 
biological control. 
6) The mass production and deployment 
of transgenic natural enemies in IPM 
programs potentially might hâve 
undesirable ecosystem effects: 
• Their extensive use could resuit in 
loss of genetic diversity of endém-
ie natural enemy populations; 
• A lack of host or prey specificity 
could affectthreatened and endan-
gered nontarget species; 
• There is a slight but unknown de-
gree of risk that a host shift to a 
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nontarget speciescould occur. (The 
genetic basis of host specificity in 
arthropod natural enemies is large-
ly unknown.) 
7)While transgenic arthropod natural 
enemies are being developed and 
evaluated in the laboratory for risk, 
they could escape accidentally. At 
présent no uniform guidelines exist 
as to how to contain transgenic ar-
thropods until they hâve been cleared 
by appropriate regulatory authorities 
for release. Containment procédures 
and guidelines were proposed by Hoy 
et al. (1997) but hâve not been widely 
discussed or adopted. It is urgent 
that we adopt consistent procédures 
and guidelines so that "every release 
is a planned release." 
RECOMMENDATIONS 
1)Evaluate methods used to deploy 
transgenic arthropod natural enemies 
(mass rearing techniques, artificial di-
ets, quality control methods, popula-
tion dynamics models) before the 
project begins. Bring ecologists and 
population geneticists, as well as IPM 
specialists, into the initial planning of 
the program so that production and 
deployment methods are known to 
be feasible and can be developed in 
a timely manner (Hoy 1995). 
2)Consider whether it makes sensé to 
develop transgenic natural enemies, 
especially if naturally-occurring bio-
types or species can be identified that 
can do the job (Hoy 1992, 1995). 
Compare relative costs, benefits, and 
risks. 
3) Develop international containment 
and risk évaluation guidelines be-
cause arthropod natural enemies can 
disperse rapidly over long distances. 
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